申请人:Orphagen Pharmaceuticals
公开号:US20130150333A1
公开(公告)日:2013-06-13
Methods for modulating (inhibiting or stimulating) retinoid-related orphan receptor γ (RORγ) activity. This modulation has numerous effects, including inhibition of T
H
-17 cell function and/or T
H
-17 cell activity, and inhibition of re-stimulation of T
H
-17 cells, which are beneficial to treatment of inflammation and autoimmune disorders. Stimulation of RORγ results in stimulation of T
H
-17 cell function and/or activity which is beneficial for immune-enhancing compositions (e.g., vaccines).
调节(抑制或刺激)视黄醇相关孤儿受体γ(RORγ)活性的方法。这种调节具有许多效果,包括抑制TH-17细胞功能和/或TH-17细胞活性,以及抑制TH-17细胞再激活,这对治疗炎症和自身免疫性疾病有益。刺激RORγ会导致TH-17细胞功能和/或活性的刺激,这对于免疫增强组合物(例如疫苗)有益。